Revenio Group Oyj
OMXH:REG1V
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.81
35.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Revenio Group Oyj
Free Cash Flow
Revenio Group Oyj
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
Free Cash Flow
€6.8m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
M
|
Modulight Oyj
OMXH:MODU
|
Free Cash Flow
-€23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bioretec Oy
OMXH:BRETEC
|
Free Cash Flow
-€3.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
Free Cash Flow
-€3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
N
|
Nexstim Oyj
OMXH:NXTMH
|
Free Cash Flow
-€3.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
B
|
Biohit Oyj
OMXH:BIOBV
|
Free Cash Flow
-€546k
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
See Also
What is Revenio Group Oyj's Free Cash Flow?
Free Cash Flow
6.8m
EUR
Based on the financial report for Dec 31, 2023, Revenio Group Oyj's Free Cash Flow amounts to 6.8m EUR.
What is Revenio Group Oyj's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
3%
Over the last year, the Free Cash Flow growth was -68%. The average annual Free Cash Flow growth rates for Revenio Group Oyj have been -21% over the past three years , -5% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
